Fractyl Health, Inc Common Stock

Yahoo Finance • 23 days ago

Fractyl Health reports Q4 results

* Fractyl Health press release [https://seekingalpha.com/pr/20449872-fractyl-health-reports-fourth-quarter-and-full-year-2025-financial-results-and-business] (GUTS [https://seekingalpha.com/symbol/GUTS]): Q4 Net Loss: For the quarter end... Full story

Yahoo Finance • 4 months ago

Biggest stock movers Tuesday: RILY, ORGO, KYTX, RC, LWLG and more

[Stock Market] sweetym/iStock via Getty Images U.S. stock futures retreated Tuesday as investors adopted a cautious stance ahead of November’s employment data, a key indicator for the labor market’s health. Here are some of Tuesday's big... Full story

Yahoo Finance • 4 months ago

Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones

BURLINGTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pioneering pattern-breaking approaches that treat root causes of obesity a... Full story

Yahoo Finance • 4 months ago

Fractyl Health says procedure can maintain weight loss after stopping GLP-1

[Successful diet. Young female in oversized jeans demonstrating results of her slimming] Prostock-Studio * Fractyl Health (GUTS [https://seekingalpha.com/symbol/GUTS]) said that data from an open-label study of its Revita outpatient end... Full story

Yahoo Finance • 4 months ago

Fractyl's Revita Procedure Shows 6-Month Post-GLP-1 Weight Stability In REVEAL-1 Study

(RTTNews) - Fractyl Health (GUTS) reported new six-month data from its open-label REVEAL-1 cohort, showing that people with obesity who stopped GLP-1 drugs maintained both weight and glycemic control after a single Revita procedure. The c... Full story

Yahoo Finance • 4 months ago

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Participants who lost 24% total body weight (>50 lbs.) on GLP-1 drugs maintained stable weight 6 months after GLP-1 discontinuation and single Revita treatment 1.5% mean weight change observed with Revita (n=17); published third-party stu... Full story

Yahoo Finance • 4 months ago

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern-breaking approaches that treat root causes of obesity and type 2 diabe... Full story

Yahoo Finance • 5 months ago

Fractyl Health outlines 2026 Revita pivotal data and PMA submission targets as clinical momentum accelerates

Earnings Call Insights: Fractyl Health (GUTS) Q3 2025 MANAGEMENT VIEW * CEO Harith Rajagopalan stated that "this quarter marked a major inflection point for Fractyl. We delivered the first randomized, double-blind, sham-controlled data... Full story

Yahoo Finance • 5 months ago

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D)... Full story

Yahoo Finance • 7 months ago

Fractyl Health stock gains after pricing of $60M underwritten offering

* Fractyl Health (NASDAQ:GUTS [https://seekingalpha.com/symbol/GUTS]) on Friday announced [https://seekingalpha.com/pr/20245642-fractyl-health-announces-pricing-of-60-million-underwritten-offering-of-common-stock] the pricing of an under... Full story

Yahoo Finance • 7 months ago

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock BURLINGTON, Mass., September 26, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics com... Full story

Yahoo Finance • 7 months ago

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

Pilot study met key 3-month efficacy endpoint with strong statistical significance (p=0.014); Revita-treated patients lost an additional 2.5% total body weight after stopping GLP-1 drugs vs. 10% regain in sham-treated patients Revita proc... Full story

Yahoo Finance • 7 months ago

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

BURLINGTON, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diab... Full story

Yahoo Finance • 8 months ago

Canaccord Genuity lowers Fractyl Health stock price target to $6 from $12

Investing.com - Canaccord Genuity lowered its price target on Fractyl Health Inc (NASDAQ:GUTS) to $6.00 from $12.00 on Thursday, while maintaining a Buy rating on the stock. The company’s shares currently trade at $1.01, with InvestingPro... Full story

Yahoo Finance • 8 months ago

Fractyl Health Posts 62% Wider Q2 Loss

Key Points Net loss (GAAP) widened 62% to $27.9 million compared to Q2 2024, as research and development spending rose 26% over the prior year period. No revenue was reported this quarter, in line with expectations. Clinical programs adva... Full story

Yahoo Finance • 8 months ago

Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference

BURLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 d... Full story

Yahoo Finance • 8 months ago

What's going on in today's session

Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] TOP GAINERS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX/profile] 86.14% SAF... Full story

Yahoo Finance • 8 months ago

Here are the top movers in Wednesday's session.

Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] TOP GAINERS TICKER CHANGE COMMENT GO [https://www.cha... Full story

Yahoo Finance • 8 months ago

The market is filled with gapping stocks in Wednesday's session.

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. [gap] GAP UP STOCKS TICKER CHANGE COMMENT SGBX [https://www.chartmill.com/stock/quote/SGBX... Full story

Yahoo Finance • 8 months ago

Fractyl Health prices $20 million public offering of common stock

BURLINGTON, Mass. - Fractyl Health, Inc. (NASDAQ:GUTS), a metabolic therapeutics company focused on treatments for obesity and type 2 diabetes, announced Wednesday the pricing of its underwritten public offering of 19,047,619 shares of com... Full story